(KMX) CarMax - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US1431301027
Stock: Used Vehicles, Financing, Protection Plans, Reconditioning
Total Rating 38
Risk 84
Buy Signal 0.23
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 41.5% |
| Relative Tail Risk | -11.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.99 |
| Alpha | -62.08 |
| Character TTM | |
|---|---|
| Beta | 1.232 |
| Beta Downside | 1.540 |
| Drawdowns 3y | |
|---|---|
| Max DD | 65.38% |
| CAGR/Max DD | -0.21 |
Description: KMX CarMax January 07, 2026
CarMax, Inc. (NYSE: KMX) is the largest U.S. retailer of used vehicles, operating through two primary segments: CarMax Sales Operations, which sells a broad inventory-including domestic, imported, luxury, hybrid, and electric models-and provides related services such as reconditioning, repairs, and extended protection plans; and CarMax Auto Finance, which offers retail financing across the credit spectrum via its own lending arm and partner institutions.
Key recent metrics illustrate the company’s positioning: Q4 2023 revenue reached $2.5 billion, with a 7% year-over-year increase in net income driven by higher average transaction prices (≈ $22,800) and improved inventory turnover (≈ 45 days). The segment’s exposure to macro-drivers-namely the persistent new-car supply shortage, elevated interest-rate sensitivity of auto loans, and growing consumer interest in EVs-remains a double-edged sword, potentially boosting used-car demand while compressing financing margins.
For a deeper, data-driven analysis of KMX’s valuation and scenario outlook, the ValueRay platform offers a concise toolkit worth exploring.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 457.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 6.39 > 1.0 |
| NWC/Revenue: 7.52% < 20% (prev 9.79%; Δ -2.27% < -1%) |
| CFO/TA 0.10 > 3% & CFO 2.48b > Net Income 457.8m |
| Net Debt (16.47b) to EBITDA (1.07b): 15.46 < 3 |
| Current Ratio: 1.99 > 1.5 & < 3 |
| Outstanding Shares: last quarter (149.4m) vs 12m ago -3.79% < -2% |
| Gross Margin: 11.31% > 18% (prev 0.11%; Δ 1120 % > 0.5%) |
| Asset Turnover: 105.3% > 50% (prev 101.8%; Δ 3.47% > 0%) |
| Interest Coverage Ratio: 6.79 > 6 (EBITDA TTM 1.07b / Interest Expense TTM 105.8m) |
Altman Z'' 1.48
| A: 0.08 (Total Current Assets 4.20b - Total Current Liabilities 2.11b) / Total Assets 25.56b |
| B: 0.16 (Retained Earnings 4.20b / Total Assets 25.56b) |
| C: 0.03 (EBIT TTM 718.3m / Avg Total Assets 26.43b) |
| D: 0.22 (Book Value of Equity 4.24b / Total Liabilities 19.50b) |
| Altman-Z'' Score: 1.48 = BB |
Beneish M -3.36
| DSRI: 0.71 (Receivables 151.1m/213.6m, Revenue 27.83b/27.80b) |
| GMI: 1.00 (GM 11.31% / 11.28%) |
| AQI: 0.99 (AQ_t 0.66 / AQ_t-1 0.67) |
| SGI: 1.00 (Revenue 27.83b / 27.80b) |
| TATA: -0.08 (NI 457.8m - CFO 2.48b) / TA 25.56b) |
| Beneish M-Score: -3.36 (Cap -4..+1) = AA |
What is the price of KMX shares?
As of February 07, 2026, the stock is trading at USD 47.17 with a total of 2,685,249 shares traded.
Over the past week, the price has changed by +5.90%, over one month by +15.25%, over three months by +52.75% and over the past year by -45.49%.
Over the past week, the price has changed by +5.90%, over one month by +15.25%, over three months by +52.75% and over the past year by -45.49%.
Is KMX a buy, sell or hold?
CarMax has received a consensus analysts rating of 3.89.
Therefore, it is recommended to buy KMX.
- StrongBuy: 8
- Buy: 4
- Hold: 4
- Sell: 3
- StrongSell: 0
What are the forecasts/targets for the KMX price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 39 | -17.3% |
| Analysts Target Price | 39 | -17.3% |
| ValueRay Target Price | 44.7 | -5.3% |
KMX Fundamental Data Overview February 03, 2026
P/E Trailing = 14.9463
P/E Forward = 17.2117
P/S = 0.235
P/B = 1.0646
P/EG = 0.7101
Revenue TTM = 27.83b USD
EBIT TTM = 718.3m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 16.59b USD (from longTermDebt, last quarter)
Short Term Debt = 796.6m USD (from shortTermDebt, last quarter)
Debt = 16.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.47b USD (from netDebt column, last quarter)
Enterprise Value = 23.01b USD (6.54b + Debt 16.68b - CCE 204.9m)
Interest Coverage Ratio = 6.79 (Ebit TTM 718.3m / Interest Expense TTM 105.8m)
EV/FCF = 11.81x (Enterprise Value 23.01b / FCF TTM 1.95b)
FCF Yield = 8.47% (FCF TTM 1.95b / Enterprise Value 23.01b)
FCF Margin = 7.00% (FCF TTM 1.95b / Revenue TTM 27.83b)
Net Margin = 1.65% (Net Income TTM 457.8m / Revenue TTM 27.83b)
Gross Margin = 11.31% ((Revenue TTM 27.83b - Cost of Revenue TTM 24.68b) / Revenue TTM)
Gross Margin QoQ = 10.64% (prev 10.63%)
Tobins Q-Ratio = 0.90 (Enterprise Value 23.01b / Total Assets 25.56b)
Interest Expense / Debt = 0.16% (Interest Expense 26.1m / Debt 16.68b)
Taxrate = 25.83% (21.7m / 83.9m)
NOPAT = 532.7m (EBIT 718.3m * (1 - 25.83%))
Current Ratio = 1.99 (Total Current Assets 4.20b / Total Current Liabilities 2.11b)
Debt / Equity = 2.75 (Debt 16.68b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = 15.46 (Net Debt 16.47b / EBITDA 1.07b)
Debt / FCF = 8.45 (Net Debt 16.47b / FCF TTM 1.95b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 457.8m / Total Assets 25.56b)
RoE = 7.39% (Net Income TTM 457.8m / Total Stockholder Equity 6.20b)
RoCE = 3.15% (EBIT 718.3m / Capital Employed (Equity 6.20b + L.T.Debt 16.59b))
RoIC = 2.17% (NOPAT 532.7m / Invested Capital 24.54b)
WACC = 3.03% (E(6.54b)/V(23.22b) * Re(10.45%) + D(16.68b)/V(23.22b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.01%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈1.30b ; Y1≈856.2m ; Y5≈390.7m
Fair Price DCF = N/A (negative equity: EV 12.45b - Net Debt 16.47b = -4.02b; debt exceeds intrinsic value)
EPS Correlation: -9.30 | EPS CAGR: -19.72% | SUE: 0.30 | # QB: 0
Revenue Correlation: -46.19 | Revenue CAGR: -6.46% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-05-31): EPS=1.07 | Chg30d=+0.021 | Revisions Net=+0 | Analysts=9
EPS next Year (2027-02-28): EPS=2.61 | Chg30d=+0.034 | Revisions Net=+1 | Growth EPS=-2.8% | Growth Revenue=+0.5%
P/E Forward = 17.2117
P/S = 0.235
P/B = 1.0646
P/EG = 0.7101
Revenue TTM = 27.83b USD
EBIT TTM = 718.3m USD
EBITDA TTM = 1.07b USD
Long Term Debt = 16.59b USD (from longTermDebt, last quarter)
Short Term Debt = 796.6m USD (from shortTermDebt, last quarter)
Debt = 16.68b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.47b USD (from netDebt column, last quarter)
Enterprise Value = 23.01b USD (6.54b + Debt 16.68b - CCE 204.9m)
Interest Coverage Ratio = 6.79 (Ebit TTM 718.3m / Interest Expense TTM 105.8m)
EV/FCF = 11.81x (Enterprise Value 23.01b / FCF TTM 1.95b)
FCF Yield = 8.47% (FCF TTM 1.95b / Enterprise Value 23.01b)
FCF Margin = 7.00% (FCF TTM 1.95b / Revenue TTM 27.83b)
Net Margin = 1.65% (Net Income TTM 457.8m / Revenue TTM 27.83b)
Gross Margin = 11.31% ((Revenue TTM 27.83b - Cost of Revenue TTM 24.68b) / Revenue TTM)
Gross Margin QoQ = 10.64% (prev 10.63%)
Tobins Q-Ratio = 0.90 (Enterprise Value 23.01b / Total Assets 25.56b)
Interest Expense / Debt = 0.16% (Interest Expense 26.1m / Debt 16.68b)
Taxrate = 25.83% (21.7m / 83.9m)
NOPAT = 532.7m (EBIT 718.3m * (1 - 25.83%))
Current Ratio = 1.99 (Total Current Assets 4.20b / Total Current Liabilities 2.11b)
Debt / Equity = 2.75 (Debt 16.68b / totalStockholderEquity, last quarter 6.06b)
Debt / EBITDA = 15.46 (Net Debt 16.47b / EBITDA 1.07b)
Debt / FCF = 8.45 (Net Debt 16.47b / FCF TTM 1.95b)
Total Stockholder Equity = 6.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.73% (Net Income 457.8m / Total Assets 25.56b)
RoE = 7.39% (Net Income TTM 457.8m / Total Stockholder Equity 6.20b)
RoCE = 3.15% (EBIT 718.3m / Capital Employed (Equity 6.20b + L.T.Debt 16.59b))
RoIC = 2.17% (NOPAT 532.7m / Invested Capital 24.54b)
WACC = 3.03% (E(6.54b)/V(23.22b) * Re(10.45%) + D(16.68b)/V(23.22b) * Rd(0.16%) * (1-Tc(0.26)))
Discount Rate = 10.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.01%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈1.30b ; Y1≈856.2m ; Y5≈390.7m
Fair Price DCF = N/A (negative equity: EV 12.45b - Net Debt 16.47b = -4.02b; debt exceeds intrinsic value)
EPS Correlation: -9.30 | EPS CAGR: -19.72% | SUE: 0.30 | # QB: 0
Revenue Correlation: -46.19 | Revenue CAGR: -6.46% | SUE: 0.99 | # QB: 1
EPS next Quarter (2026-05-31): EPS=1.07 | Chg30d=+0.021 | Revisions Net=+0 | Analysts=9
EPS next Year (2027-02-28): EPS=2.61 | Chg30d=+0.034 | Revisions Net=+1 | Growth EPS=-2.8% | Growth Revenue=+0.5%